MORGAN STANLEY

Position in INBX — Inhibrx Biosciences, Inc.

CIK 895421 NEW YORK, NY

Position in INBX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$84,916,731

-$7,333,781 QoQ

Shares Held

1,263,078

+8.2% QoQ

Ownership

8.61%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 98.66880746873906.ToString("F0")% Shared 0.ToString("F0")% None 1.3311925312609356.ToString("F0")%

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,423,671,747 across 511 Biotechnology names. INBX ranks #35 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$84,916,731	1,263,078	+8.2%	Shares	Defined	2026-05-15
2025-12-31	$92,250,512	1,167,728	+163.7%	Shares	Defined	2026-05-27
2025-09-30	$14,915,388	442,856	+1492.5%	Shares	Defined	2026-05-27
2025-06-30	$396,817	27,808	-24.6%	Shares	Defined	2025-08-15
2025-03-31	$516,228	36,900	-7.1%	Shares	Defined	2025-05-15
2024-12-31	$611,608	39,715	-83.4%	Shares	Defined	2025-05-15
2024-09-30	$3,746,495	239,240	+1.4%	Shares	Defined	2025-05-14
2024-06-30	$3,342,926	235,916	—	Shares	Defined	2025-05-14
No filing history on record for this holder in this stock.